Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulseAugust 24, 2006Treating malignant tumours is difficult. Doctors have to destroy the tumour, but healthy tissue needs to be preserved. Chemotherapy tends to kill diseased cells, at the same time causing great damage to the body in general. So scientists are looking for ways to destroy only the rampant tumour cells. One way to achieve this is to transport substances inside of microcapsules into the tumour cells and release them there. Researchers led by André Skirtach and Gleb Sukhorukov at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, along with Wolfgang Parak at Ludwig-Maximilian-University in Munich, have now used a laser as a means of opening microcapsules inserted into a tumour cell. The capsules subsequently release their contents, a fluorescent test substance, into the cell. The scientists used a light microscope to monitor how the luminous materials distribute themselves within the cell. The vehicle that the researchers used was a polymer capsule only a few micrometres in diameter. The walls of the capsules were built from a number of layers of charged polymers, alternating positive and negative. In the laboratory, at least, this is an established way of producing transport containers for medicines, cosmetics, or nutrients, which can also pass through cell membranes. André Skirtach and his colleagues equipped the capsules with a kind of "open sesame". But it didn't require any magic-just nanoparticles made of gold or silver atoms. The scientists mixed together charged metal nanoparticles along with the polymers composing the walls of the vesicle. The tumour cells absorbed the microcapsules and then the scientists aimed an infrared laser at them. Metal nanoparticles are particularly good at absorbing the laser light and transmitting the heat further into their surroundings, heating up the walls. They became so hot that the bonds broke between the polymers and the shell and the capsules eventually opened. For the time being, the scientists have only been trying out their methods on isolated tumour cells. "In principle, however, active substances could be released into the body this way," says Helmuth Möhwald, director of the Max Planck Institute of Colloids and Interfaces, and one of the participating scientists. This has to (do) with the fact that infrared laser light can penetrate at least one centimetre deep into the tissue. The cells of the body heat up negligibly because laser light at this wavelength is insignificantly absorbed in the tissue. It is the metal particles in the walls of the microcapsules only that absorb the light-even when the microcapsules are in a cell, because the laser affects only them.
Besides using a "thermal opener", the scientists have found another way of making the capsules more stable. They simply heat up the newly created microcapsules very slightly, so that the diameter of the hollow capsules becomes smaller. At the same time, the molecules in their shell are located closer to each other, thickening the capsule walls and better protecting their contents. There is still, however, a major problem to solve before scientists can use this technology to create medicines which squeeze microcapsules into tumour cells. There is still no way to "steer" the microcapsules. Helmuth Möhwald says, "we have to add some kind of feature to the capsules so that they only recognise the target cells." Only these cells would then allow microcapsules through their membrane. Max Planck Society for the Advancement of Science | |||||||||||||||||||||
|
Related Tumour News Articles Cancer cells with a long breath: seeking the origin of brain tumors in children Medulloblastoma is one of the most common and most malignant brain tumours among children and teenagers. These tumours grow very rapidly, and fifty percent of patients in the long term die from the condition. Monash researchers uncover cancer survival secrets A team of Monash University researchers has uncovered the role of a family of enzymes in the mutation of benign or less aggressive tumours into more aggressive, potentially fatal, cancers in the human body. How chemo kills tumours: research to reduce side effects Dr Stephen Taylor and Karen Gascoigne at the University's Faculty of Life Sciences have taken a new systematic approach to studying anti-mitotic drugs, which are used extensively for breast or ovarian cancer in the UK. Discovery of a mechanism that regulates cell movement A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with researchers at the Instituto de Biología Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion. First worldwide analysis of cancer survival finds wide variation between countries Cancer survival varies widely between countries according to a worldwide study published online today in Lancet Oncology.* More than 100 investigators contributed to the study. Scientists from the University of Navarra find 5 genes involved in the metastasis of breast tumours to the lung The identification of five genes involve in the metastasis of breast tumours to the lung is the principal finding of a scientific team made up of two bodies from the University of Navarra, the Applied Medical Research Centre (CIMA) and the University Hospital of the University of Navarra. Improving understanding of cell behaviour in breast cancer The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. 30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho Tocilizumab plus methotrexate showed significant clinical improvements in efficacy and safety in patients with moderate to severe rheumatoid arthritis (RA), who had not adequately responded to anti-tumour necrosis factor (anti-TNF) therapy. Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases The TRAF1/C5 locus on chromosome 9 has been revealed to play a role in multiple autoimmune diseases including type 1 diabetes and systemic lupus erythematosus (SLE). Flower power may bring ray of sunshine to cancer sufferers A mini-protein found in sunflower seeds could be the key to stopping tumors spreading in prostate cancer patients, according to QUT researchers. More Tumour News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||